Key Takeaways

• Google requires LegitScript Certification before any addiction treatment ad account can serve ads promoting recovery-oriented services.
• EKRA makes it a federal crime to pay or receive compensation tied to patient referrals, including commission-based PPC lead arrangements, punishable by up to 10 years in prison — and unlike the older Anti-Kickback Statute, EKRA applies regardless of payor, covering privately insured and self-pay admissions.
• The FTC fined Evoke Wellness $1.9 million in June 2025 for running 68,510 Google search ads that impersonated competitor treatment clinics.
• Ad copy that uses a competitor’s trademarked clinic name to redirect callers violates both Google Ads policy and the Opioid Addiction Recovery Fraud Prevention Act.
• Certification requirements differ by country: full LegitScript certification applies in the U.S. and Canada, while government entities only may advertise in Australia, France, Ireland, and New Zealand.
• Non-compliant accounts face suspension without prior warning, and FTC violations carry civil penalties independent of any Google Ads enforcement action.
• A compliant PPC program treats certification, ad copy content, and call handling as three separate compliance surfaces, not one.

What Counts as a PPC Ad Copy Regulation for Drug Rehab Marketing?

A PPC ad copy regulation for drug rehab marketing is any platform policy or federal law that governs what an ad can say, who can run it, and what happens after a click. Three sources create these regulations. Google Ads policy governs eligibility and content through its healthcare and medicines advertising policy. Federal statute governs compensation structures through EKRA. Federal enforcement governs deceptive claims and impersonation through the FTC Act and the Opioid Addiction Recovery Fraud Prevention Act of 2018. Each source applies independently — passing one does not satisfy the others.

A rehab marketer who only checks Google’s certification box still risks an EKRA violation if the agency running the campaign earns a commission per admitted patient. A marketer who avoids EKRA violations still risks an FTC action if the ad copy uses a competitor’s clinic name to redirect callers to a different facility. Compliance requires clearing all three sources before a single ad goes live.

These regulations exist because paid search has become a primary entry point into addiction treatment for people in crisis. A person searching for help at the point of relapse or withdrawal is a uniquely vulnerable searcher, and federal regulators treat ad copy aimed at that moment with the same scrutiny applied to any other high-stakes health care claim. Marketing directors evaluating a PPC vendor should ask how each of the three compliance sources is monitored on an ongoing basis, not only confirmed once at account setup.

Ad copy regulation does not stop at the ad itself. Google and the FTC both evaluate the destination page and the intake process the ad leads to as part of the same compliance review. An ad that passes copy review but sends traffic to a landing page misrepresenting the facility, or into a call center trained to redirect callers to a different provider, still creates the liability the regulations exist to prevent.

LegitScript Certification: The Gateway to Running Rehab Ads on Google

LegitScript Certification is the credential Google requires before approving any ad that promotes recovery-oriented drug and alcohol addiction services. Google’s advertiser policy states that advertisers must be certified as an addiction services provider to run these ads, and applies this requirement to search, display, and video campaigns alike. An uncertified account will see every addiction-related ad disapproved on review, regardless of how the copy is written.

Geographic scope narrows who can advertise at all. The United States and Canada require full LegitScript addiction treatment certification. Australia, France, Ireland, and New Zealand restrict addiction services advertising to government entities only. Most other countries prohibit addiction services advertising outright. A treatment center expanding PPC campaigns into a new country must confirm eligibility before building out ad groups, not after.

Certification is a prerequisite, not a guarantee. A certified account that later runs ad copy violating other Google policies — trademark misuse, unsubstantiated claims, or misleading destination URLs — still faces disapproval or suspension on a per-ad or per-account basis. Certification also lapses. A treatment center that lets its LegitScript status expire mid-campaign loses ad serving eligibility immediately, which means renewal tracking belongs on the same compliance calendar as ad copy review, not treated as a one-time setup task.

EKRA and the Ban on Pay-Per-Call, Pay-Per-Lead Ad Arrangements

The Eliminating Kickbacks in Recovery Act makes it a federal crime to knowingly solicit, receive, pay, or offer payment for referrals to a recovery home, clinical treatment facility, or laboratory. Congress enacted EKRA in October 2018 to target patient brokering and the profiteering that fueled the opioid crisis. A violation carries a fine, up to 10 years in prison, or both.

EKRA reaches directly into PPC campaign structure. A marketing agency or call center that earns a per-lead, per-call, or per-admission commission from a treatment center’s PPC campaign risks structuring an illegal kickback, even when the arrangement is labeled as a standard marketing fee. The Department of Justice has prosecuted this exact pattern under its Sober Homes Initiative, a partnership between U.S. Attorneys’ Offices in the Central District of California and South Florida targeting patient brokering schemes tied to addiction treatment marketing.

The safest PPC compensation structure pays for media spend and management time, not for the number of patients an ad campaign delivers. A flat retainer or percentage-of-ad-spend fee avoids the compensation-per-referral structure EKRA prohibits.

EKRA closes a gap the older federal Anti-Kickback Statute (AKS) left open. The HHS Office of Inspector General limits AKS to remuneration tied to business payable by federal health care programs such as Medicare and Medicaid. EKRA contains no such limitation: it applies to referral payments regardless of payor, covering privately insured and self-pay rehab admissions that AKS never reached. A PPC compensation model built to satisfy AKS alone does not satisfy EKRA, since most rehab admissions driven by paid search involve private insurance or self-pay patients rather than Medicare or Medicaid beneficiaries.

FTC Ad Copy Rules Under the Opioid Addiction Recovery Fraud Prevention Act

The Opioid Addiction Recovery Fraud Prevention Act of 2018 makes it unlawful to engage in an unfair or deceptive act or practice involving any substance use disorder treatment service. The FTC enforces this standard against the ad copy itself, not only against the underlying treatment claims.

The FTC’s June 2025 settlement with Evoke Wellness demonstrates how ad copy alone can trigger enforcement. Evoke ran Google search ads using competitor clinic names as keywords, then paired those names with Evoke’s own call center number in the ad copy — effectively impersonating the clinics people were searching for. Telemarketers who answered those calls let searchers believe they had reached the specific facility they searched for before redirecting them to Evoke’s own centers. The scheme ran from 2021 through 2023, generated at least 68,510 misleading search ads, and produced at least 3,500 calls from people seeking substance use disorder treatment. Evoke agreed to pay $1.9 million, with a $7 million penalty suspended pending compliance, and accepted a permanent ban on impersonating other treatment providers in future advertising.

The FTC’s general health claims guidance applies on top of this case-specific ruling: any claim about treatment outcomes, success rates, or medical effectiveness in ad copy requires competent and reliable scientific evidence before publication, not after a complaint arrives.

The Evoke Wellness settlement functions as a warning to the entire addiction treatment marketing industry, not only to the company named in the complaint. The FTC’s press release framed the case as enforcement of a statute passed specifically to protect people searching for substance use disorder treatment from deceptive marketing, signaling that ad copy impersonating a competitor clinic is now an active enforcement priority rather than a rarely-pursued technicality.

Trademark and Competitor-Name Restrictions in Ad Copy

Google Ads policy permits bidding on a competitor’s trademarked name as a keyword but prohibits using that trademark inside the visible ad copy without the trademark owner’s permission. A rehab marketer can target “[Competitor Name] alternative” as a keyword; the ad headline and description cannot display the competitor’s name unless authorized.

The Evoke Wellness case shows what happens when ad copy crosses this line in a healthcare context: pairing a competitor’s clinic name with a different facility’s phone number does not just risk a Google policy violation, it constitutes the deceptive impersonation the FTC treats as a federal law violation. Ad copy referencing a competitor by name, even indirectly through a matching phone number or matching landing page branding, carries legal exposure beyond a standard trademark dispute.

Trademark owners can file a complaint directly with Google when they find their name displayed in a competitor’s ad text, which can trigger an ad copy review independent of any FTC action. A rehab marketing team running competitive campaigns should audit ad copy for competitor names on a recurring schedule, not only at campaign launch, since new ad variations added during optimization can reintroduce a trademark violation that the original launch review caught and removed.

Platform Differences: Google Ads vs. Microsoft Advertising vs. Meta

Google Ads applies the strictest, most codified certification requirement of the major platforms, requiring LegitScript Certification before any addiction services ad serves. Microsoft Advertising and Meta apply their own healthcare advertising policies to addiction treatment campaigns, but neither platform’s certification pathway is addressed in Google’s public policy documentation, so a marketer running cross-platform PPC campaigns must confirm each platform’s current requirement separately rather than assuming Google’s rules transfer.

Federal law, unlike platform policy, applies uniformly regardless of which platform serves the ad. EKRA’s referral-payment restrictions and the FTC’s deceptive-advertising authority under the Opioid Addiction Recovery Fraud Prevention Act govern ad copy and compensation structure on Google, Microsoft, Meta, or any other channel identically. A campaign that clears one platform’s certification review is not exempt from federal statute.

A multi-platform PPC strategy should treat certification as a per-platform task and treat federal compliance as a single standard applied everywhere. Building one ad copy library, then submitting it separately to each platform’s review process, is safer than assuming an approval on Google carries over to Microsoft Advertising or Meta.

Building a Compliant PPC Ad Copy Checklist

A compliant PPC launch checklist for a drug rehab center confirms four items before the first ad goes live. First, LegitScript Certification is active and matches the country the campaign targets. Second, the agency or vendor compensation structure pays for media spend or management time, not per lead, per call, or per admission. Third, ad copy contains no competitor clinic names, trademarks, or phone numbers belonging to another facility. Fourth, any outcome or success-rate claim in the ad copy has documented, verifiable support before publication. Reviewing all four items on a recurring basis, not only at launch, catches the compliance drift that happens as new ad variations, landing pages, and call center scripts get added during ongoing optimization.

Frequently Asked Questions

Does Google require certification to run drug rehab PPC ads?

Google requires LegitScript Certification as an addiction services provider before approving any ad promoting recovery-oriented drug and alcohol addiction services, applied across search, display, and video campaigns.

Can a rehab center legally pay for patient referrals generated through PPC ads?

A rehab center cannot legally pay a commission tied to patient referrals under EKRA, which criminalizes payment for referrals to a recovery home or clinical treatment facility with penalties of up to 10 years in prison.

Can rehab PPC ads bid on a competitor’s brand name as a keyword?

Google Ads policy allows bidding on a competitor’s trademarked name as a keyword but prohibits displaying that trademark inside the visible ad copy without the owner’s permission.

What happened in the FTC’s case against Evoke Wellness?

The FTC settled with Evoke Wellness for $1.9 million in June 2025 after finding the company ran 68,510 Google search ads that used competitor clinic names to impersonate those clinics and redirect callers to Evoke’s own treatment centers.

Does Microsoft Advertising require the same certification as Google?

Microsoft Advertising applies its own healthcare advertising policy to addiction treatment campaigns, and marketers must confirm its current certification requirement directly with the platform rather than assuming Google’s LegitScript requirement transfers.

What is the penalty for running non-compliant rehab PPC ads?

Non-compliant rehab PPC ads risk immediate account suspension by Google without prior warning, plus separate federal civil penalties from the FTC that can reach millions of dollars under the Opioid Addiction Recovery Fraud Prevention Act.

What is the difference between EKRA and the federal Anti-Kickback Statute?

The federal Anti-Kickback Statute applies only to referral payments tied to federal health care programs such as Medicare and Medicaid, while EKRA applies regardless of payor, covering privately insured and self-pay rehab admissions that the older statute does not reach.